Identification of Avramr1 from Phytophthorainfestans utilizing lengthy learn and cDNA pathogen-enrichment sequencing (PenSeq)
Potato late blight, brought on by the oomycete pathogen Phytophthorainfestans, considerably hampers potato manufacturing. Lately, a brand new Resistance to Phytophthorainfestans (Rpi) gene, Rpi-amr1, was cloned from a wild Solanum species, Solanumamericanum.
Identification of the corresponding acknowledged effector (Avirulence or Avr) genes from P. infestans is essential to elucidating their naturally occurring sequence variation, which in flip informs the potential sturdiness of the cognate late blight resistance. To establish the P. infestans effector acknowledged by Rpi-amr1, we screened obtainable RXLR effector libraries and used lengthy learn and cDNA pathogen-enrichment sequencing (PenSeq) on 4 P. infestans isolates to discover the untested effectors.
Utilizing single-molecule real-time sequencing (SMRT) and cDNA PenSeq, we recognized 47 extremely expressed effectors from P. infestans, together with PITG_07569, which triggers a extremely particular cell loss of life response when transiently coexpressed with Rpi-amr1 in Nicotianabenthamiana, suggesting that PITG_07569 is Avramr1. Right here we display that lengthy learn and cDNA PenSeq allows the identification of full-length RXLR effector households and their expression profile. This examine has revealed key insights into the evolution and polymorphism of a fancy RXLR effector household that’s related to the popularity by Rpi-amr1.
asean-ndi
) VEGF E (Orf Virus) |
|
cyt-263 |
ProSpec Tany |
2µg |
EUR 60 |
|
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
 Orf Virus VEGF-E, Heparin-binding |
|
MBS691480-002mg |
MyBiosource |
0.02mg |
EUR 440 |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691480-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1685 |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691994-0005mg |
MyBiosource |
0.005mg |
EUR 300 |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691994-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1050 |
 Orf virus VEGF-E Recombinant Protein |
|
300-044 |
ReliaTech |
5 µg |
EUR 136.5 |
|
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|
300-044S |
ReliaTech |
2 µg |
EUR 73.5 |
|
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|
300-045 |
ReliaTech |
20 µg |
EUR 357 |
|
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
 Anti-Orf Virus VEGF-E Antibody |
|
102-PA70 |
ReliaTech |
50 µg |
EUR 115.5 |
|
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
 Protein, His, E.coli-1mg) Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
|
QP10912-1mg |
EnQuireBio |
1mg |
EUR 6181.2 |
 Protein, His, E.coli-2ug) Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
|
QP10912-2ug |
EnQuireBio |
2ug |
EUR 186 |
 Protein, His, E.coli-10ug) Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
|
QP10912-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
 Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|
300-046 |
ReliaTech |
20 µg |
EUR 194.25 |
|
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|
300-046S |
ReliaTech |
5 µg |
EUR 94.5 |
|
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
) VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
|
PROTQ2F842 |
BosterBio |
Regular: 10ug |
EUR 250 |
|
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
 (Recombinant) Human) ov-VEGF-E (Orf virus) (Recombinant) Human |
|
GWB-C8AD60 |
GenWay Biotech |
0.005 mg |
Ask for price |
) VEGFE protein (Orf virus) |
|
30R-AV011 |
Fitzgerald |
5 ug |
EUR 381 |
|
|
|
Description: Purified recombinant VEGFE protein (Orf virus) |
VEGFE protein (Orf virus) |
|
MBS538323-0005mg |
MyBiosource |
0.005mg |
EUR 505 |
VEGFE protein (Orf virus) |
|
MBS538323-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 2125 |
 Recombinant Orf Virus VEGFE Protein |
|
VAng-Lsx0417-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
 Recombinant Orf Virus VEGFE Protein [His] |
|
VAng-Lsx0418-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
 Cytochalasin E |
|
C197-1MG |
TOKU-E |
1 mg |
EUR 79.77 |
|
|
|
Description: 36011-19-5 |
Cytochalasin E |
|
C197-5MG |
TOKU-E |
5 mg |
EUR 276.58 |
|
|
|
Description: 36011-19-5 |
 Chevalone E |
|
C257-0.5MG |
TOKU-E |
0.5 mg |
EUR 153.46 |
|
|
|
Description: 1315451-94-5 |
Chevalone E |
|
C257-2.5MG |
TOKU-E |
2.5 mg |
EUR 536.69 |
|
|
|
Description: 1315451-94-5 |
 Berkeleylactone E |
|
B087-1MG |
TOKU-E |
1 mg |
EUR 145.66 |
|
|
|
Description: 122211-62-5 |
Berkeleylactone E |
|
B087-5MG |
TOKU-E |
5 mg |
EUR 509.81 |
|
|
|
Description: 122211-62-5 |
 Deoxybrevianamide E |
|
D083-1MG |
TOKU-E |
1 mg |
EUR 191.61 |
|
|
|
Description: 34610-68-9 |
Deoxybrevianamide E |
|
D083-5MG |
TOKU-E |
5 mg |
EUR 670.21 |
|
|
|
Description: 34610-68-9 |
 Oligomycin E |
|
O021-1MG |
TOKU-E |
1 mg |
EUR 212.42 |
|
|
|
Description: 110231-34-0 |
Oligomycin E |
|
O021-5MG |
TOKU-E |
5 mg |
EUR 741.31 |
|
|
|
Description: 110231-34-0 |
 Paraherquamide E |
|
P070-0.5MG |
TOKU-E |
0.5 mg |
EUR 271.38 |
|
|
|
Description: 125600-53-5 |
Paraherquamide E |
|
P070-2.5MG |
TOKU-E |
2.5 mg |
EUR 947.66 |
|
|
|
Description: 125600-53-5 |
 Phenelfamycin E |
|
P078-1MG |
TOKU-E |
1 mg |
EUR 212.42 |
|
|
|
Description: 114451-31-9 |
Phenelfamycin E |
|
P078-5MG |
TOKU-E |
5 mg |
EUR 741.31 |
|
|
|
Description: 114451-31-9 |
 Roquefortine E |
|
R035-1MG |
TOKU-E |
1 mg |
EUR 150 |
|
|
|
Description: 871982-52-4 |
Roquefortine E |
|
R035-5MG |
TOKU-E |
5 mg |
EUR 524.55 |
|
|
|
Description: 871982-52-4 |
 Azithromycin impurity E EvoPure® |
|
A074-5MG |
TOKU-E |
5 mg |
EUR 605.18 |
|
|
|
Description: 612069-27-9 |
 Hepatitis E virus ORF 3 Recombinant Protein |
|
53-335 |
ProSci |
0.01 mg |
EUR 651.3 |
|
Description: Hepatitis E virus ORF 3 Recombinant Protein |
 Hepatitis E virus ORF 2 Recombinant Protein |
|
53-336 |
ProSci |
0.01 mg |
EUR 651.3 |
|
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|
53-337 |
ProSci |
0.01 mg |
EUR 651.3 |
|
Description: Hepatitis E virus ORF 2 Recombinant Protein |
 Protein) Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
abx263083-10mg |
Abbexa |
10 mg |
EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
20-abx263083 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
abx263083-25mg |
Abbexa |
25 mg |
EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
abx263083-5mg |
Abbexa |
5 mg |
EUR 225 |
) Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|
MBS1007472-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|
MBS1007472-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|
MBS1007472-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|
MBS1007472-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|
MBS1007472-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 870 |
) Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
7-01759 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
7-01760 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
7-01761 |
CHI Scientific |
1mg |
Ask for price |
, (Recombinant)) Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant) |
|
22060748-1 |
Bio-WORLD |
2 µg |
EUR 190.94 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
cyt-263-10g |
ProSpec Tany |
10µg |
EUR 145 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
cyt-263-1mg |
ProSpec Tany |
1mg |
EUR 5100 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
cyt-263-2g |
ProSpec Tany |
2µg |
EUR 60 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
MBS142140-0002mg |
MyBiosource |
0.002mg |
EUR 240 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
MBS142140-001mg |
MyBiosource |
0.01mg |
EUR 310 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
MBS142140-1mg |
MyBiosource |
1mg |
EUR 5325 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|
MBS142140-5x1mg |
MyBiosource |
5x1mg |
EUR 23640 |
) Vascular Endothelial Growth Factor-E Recombinant (Orf Virus) |
|
rAP-2496 |
Angio Proteomie |
Inquiry |
Ask for price |
 Hepatitis E Virus ORF3 Protein |
|
20-abx260138 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Hepatitis E Virus ORF3 Protein |
|
abx260138-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF3 Protein |
|
abx260138-5g |
Abbexa |
5 µg |
EUR 350 |
 Hepatitis E virus |
|
8942 |
Virostat |
100 ug |
EUR 340 |
|
Description: ORF 2 |
Hepatitis E virus |
|
8943 |
Virostat |
100 ug |
EUR 340 |
|
Description: ORF 2 |
Hepatitis E virus |
|
8944 |
Virostat |
100 ug |
EUR 340 |
|
Description: ORF 3 |
Hepatitis E virus |
|
MBS328020-01mg |
MyBiosource |
0.1mg |
EUR 435 |
Hepatitis E virus |
|
MBS328020-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1865 |
Hepatitis E virus |
|
MBS328021-01mg |
MyBiosource |
0.1mg |
EUR 435 |
Hepatitis E virus |
|
MBS328021-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1865 |
Hepatitis E virus |
|
MBS328022-01mg |
MyBiosource |
0.1mg |
EUR 435 |
Hepatitis E virus |
|
MBS328022-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1865 |
Hepatitis E virus |
|
PCR-H498-PCRH49848R |
Bioingentech |
PCR-H498-48R |
EUR 485 |
Hepatitis E virus |
|
PCR-H498-PCRH49896R |
Bioingentech |
PCR-H498-96R |
EUR 685 |
Hepatitis E virus |
|
Oneq-H498-OneqH498100R |
Bioingentech |
Oneq-H498-100R |
EUR 1028 |
Hepatitis E virus |
|
Oneq-H498-OneqH498150R |
Bioingentech |
Oneq-H498-150R |
EUR 1438 |
Hepatitis E virus |
|
Oneq-H498-OneqH49850R |
Bioingentech |
Oneq-H498-50R |
EUR 728 |
 Recombinant Hepatitis E Virus ORF3 |
|
7-07450 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|
7-07451 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|
7-07452 |
CHI Scientific |
1000µg |
Ask for price |
) Hepatitis E Virus ORF3 (Recombinant) |
|
22060181-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
Recombinant Hepatitis E Virus ORF3 |
|
MBS142588-01mg |
MyBiosource |
0.1mg |
EUR 330 |
Recombinant Hepatitis E Virus ORF3 |
|
MBS142588-05mg |
MyBiosource |
0.5mg |
EUR 825 |
Recombinant Hepatitis E Virus ORF3 |
|
MBS142588-1mg |
MyBiosource |
1mg |
EUR 1515 |
Recombinant Hepatitis E Virus ORF3 |
|
MBS142588-5x1mg |
MyBiosource |
5x1mg |
EUR 6485 |
 Hepatitis E Virus ORF3 Recombinant |
|
rAP-5321 |
Angio Proteomie |
Inquiry |
Ask for price |
) Hepatitis E Virus, ORF2, Recombinant (HEV) |
|
MBS637880-01mg |
MyBiosource |
0.1mg |
EUR 455 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|
MBS637880-05mg |
MyBiosource |
0.5mg |
EUR 1025 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|
MBS637880-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4470 |
) Hepatitis E Virus, ORF3, Recombinant (HEV) |
|
MBS636730-01mg |
MyBiosource |
0.1mg |
EUR 735 |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
|
MBS636730-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3155 |
: Human Recombinant E Coli) VEGF (165): Human Recombinant E Coli |
|
GWB-BDEFEF |
GenWay Biotech |
1 mg |
Ask for price |
 Protein) Hepatitis E Virus ORF2 (452-617) Protein |
|
20-abx260268 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Hepatitis E Virus ORF2 (452-617) Protein |
|
abx260268-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF2 (452-617) Protein |
|
abx260268-5g |
Abbexa |
5 µg |
EUR 350 |
 Protein) Hepatitis E Virus ORF2 (633-659) Protein |
|
20-abx260269 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
|
abx260269-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (633-659) Protein |
|
abx260269-5g |
Abbexa |
5 µg |
EUR 350 |
 Protein) Hepatitis E Virus ORF2 (403-461) Protein |
|
20-abx260270 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
|
abx260270-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (403-461) Protein |
|
abx260270-5g |
Abbexa |
5 µg |
EUR 350 |
) Hepatitis E virus (ratHEV) |
|
PCR-V372-PCRV37248R |
Bioingentech |
PCR-V372-48R |
EUR 485 |
Hepatitis E virus (ratHEV) |
|
PCR-V372-PCRV37296R |
Bioingentech |
PCR-V372-96R |
EUR 685 |
Hepatitis E virus (ratHEV) |
|
Oneq-V372-OneqV372100R |
Bioingentech |
Oneq-V372-100R |
EUR 1028 |
Hepatitis E virus (ratHEV) |
|
Oneq-V372-OneqV372150R |
Bioingentech |
Oneq-V372-150R |
EUR 1438 |
Hepatitis E virus (ratHEV) |
|
Oneq-V372-OneqV37250R |
Bioingentech |
Oneq-V372-50R |
EUR 728 |
) Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|
MBS1215198-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 995 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|
MBS1215198-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 560 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|
MBS1215198-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 750 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|
MBS1215198-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 670 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A) |
|
MBS1215198-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 875 |
) Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|
MBS1205850-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1005 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|
MBS1205850-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 570 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|
MBS1205850-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 755 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|
MBS1205850-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 680 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
|
MBS1205850-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 885 |
) Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|
MBS1182981-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|
MBS1182981-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|
MBS1182981-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|
MBS1182981-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D) |
|
MBS1182981-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 870 |
) Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|
MBS1177237-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1015 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|
MBS1177237-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 585 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|
MBS1177237-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 770 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|
MBS1177237-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 700 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
|
MBS1177237-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 900 |
) Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|
MBS1122067-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|
MBS1122067-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|
MBS1122067-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|
MBS1122067-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
|
MBS1122067-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 870 |
) Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E) |
|
MBS1252431-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 995 |
Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31: cDNA cloning, expression and initial characterization of morphine metabolism
Goal: Uridine diphospho-glucuronosyltransferases (UGTs) are membrane-bound enzymes that catalyze the conjugation of glucuronic acid onto a various set of xenobiotics. Horses effectively and extensively glucuronidate a lot of xenobiotics, together with opioids, making UGTs an vital group of drug-metabolizing enzymes for the clearance of medication. Recombinant enzymes have allowed researchers to characterize the metabolism of a wide range of medication. The first goal was to clone, specific and characterize equine UGTs utilizing medication characterised as UGT substrates in different species. A secondary goal was to characterize the in vitro metabolism of morphine in horses.
Examine design: In vitro drug metabolism examine utilizing liver microsomes and recombinant enzyme methods.
Animals: Liver microsomes and RNA from tissue collected from two Thoroughbred mares euthanized for different causes.
Strategies: Primarily based on homology to the human UGT2B7, 4 equine UGT variants have been expressed: UGT1A1, UGT2A1, UGT2B31 and UGT2B4. cDNA sequences have been cloned and ensuing protein expressed in a baculovirus expression system. Performance of the enzymes was assessed utilizing 4-methylumbelliferone, testosterone, diclofenac and ketoprofen. Recombinant enzyme, management cells, equine liver microsomes and human UGT2B7 supersomes have been then incubated with morphine. Concentrations of metabolites have been measured utilizing liquid chromatography-tandem mass spectrometry and enzyme kinetics decided.
Outcomes: 4-Methylumbelliferone was glucuronidated by all expressed equine UGTs. Testosterone glucuronide was not produced by any of the expressed enzymes, and diclofenac glucuronide and ketoprofen glucuronide have been produced by UG2A1 and UGT1A1, respectively. UGT2B31 metabolized morphine to morphine-3-glucuronide and low concentrations of morphine-6-glucuronide.
Conclusions and scientific relevance: That is the primary profitable expression of useful recombinant equine UGTs. UGT2B31 contributes to the glucuronidation of morphine; nonetheless, it’s in all probability not the primary metabolizing enzyme. These outcomes warrant additional investigation of equine UGTs, together with expression of further enzymes and additional characterization of UGT2B31 as a contributor to morphine metabolism.
An progressive genosensor for the monitoring of Leishmaniaspp sequence utilizing binding of pDNA to cDNA primarily based on Cit-AgNPs
Leishmaniasis thought of as essentially the most essential epidemic-prone illnesses based on the World Well being Group. Early diagnoses and remedy of Leishmania an infection is a good problem since, it has no symptom and is resistance to medication. Subsequently, there’s an pressing want for delicate and exact detection of this pathogen.
On this examine, a brand new technique was developed for optical biosensing of Leishmaniaspp sequence primarily based on hybridization of Citrate capped Ag nanoparticles bonded to particular single stranded DNA probe of Leishmania spp. Aggregation of the Citrate capped Ag nanoparticles within the existence or lack of a cDNA sequence of Leishmania, trigger eye catching and appreciable vital alter within the UV-vis.
The obtained low restrict of quantification (LLOQ) of was achieved as 1ZM. Primarily based on experimental ends in optimum situations, fast bioanalysis of Leishmaniaspp sequence was carried out (2 min). So, this probe can be utilized for the scientific analysis of this pathogen and an infection illness.
RNA-cDNA hybrids mediate transposition via different mechanisms
Retrotransposons can represent half of eukaryotic genomes. Retrotransposon dysregulation destabilizes genomes and has been linked to various human diseases. Emerging regulators of retromobility include RNA-DNA hybrid-containing structures known as R-loops. Accumulation of these structures at the transposons of yeast 1 (Ty1) elements has been shown to increase Ty1 retromobility through an unknown mechanism. Here, via a targeted genetic screen, we identified the rnh1Δ rad27Δ yeast mutant, which lacked both the Ty1 inhibitor Rad27 and the RNA-DNA hybrid suppressor Rnh1. The mutant exhibited elevated levels of Ty1 cDNA-associated RNA-DNA hybrids that promoted Ty1 mobility. Moreover, in this rnh1Δ rad27Δ mutant, but not in the double RNase H mutant rnh1Δ rnh201Δ, RNA-DNA hybrids preferentially existed as duplex nucleic acid structures and increased Ty1 mobility in a Rad52-dependent manner.
The data indicate that in cells lacking RNA-DNA hybrid and Ty1 repressors, elevated levels of RNA-cDNA hybrids, which are associated with duplex nucleic acid structures, boost Ty1 mobility via a Rad52-dependent mechanism. In contrast, in cells lacking RNA-DNA hybrid repressors alone, elevated levels of RNA-cDNA hybrids, which are associated with triplex nucleic acid structures, boost Ty1 mobility via a Rad52-independent process. We propose that duplex and triplex RNA-DNA hybrids promote transposon mobility via Rad52-dependent or -independent mechanisms.
Identification of salinity responsive genes in lavender through cDNA-AFLP
Currently, a global demand exists forlavender as a significant medicinal plant and source of essential oils. Freshwater and arable lands are two major factors that inhibit extensive farming of medicinal plants in Iran. Saline water from seas and salty soil may be new resources for agricultural use, especially for medicinal plants.
We sought to extend our knowledge of the Lavandula angustifolia genome and molecular basis of its salinity tolerance by using cDNA amplified fragment length polymorphism (cDNA-AFLP) to investigate the changes in plant transcriptomes in response to NaCl.
All identified transcript derived fragments (TDF) were assigned as novel L. angustifolia genes related to signal transduction, regulation of gene expression, alternative splicing, autophagy, and secondary metabolite biosynthesis. qRT-PCR analysis of the TDFs in response to different concentrations of NaCl revealed various levels of mRNA of the identified genes in this plant. Our findings provided primary insights into the molecular response of L. angustifolia to salinity.
VEGFE protein (Orf virus) |
|
MBS538323-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 2125 |
Recombinant Orf Virus VEGFE Protein |
|
VAng-Lsx0417-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
Recombinant Orf Virus VEGFE Protein [His] |
|
VAng-Lsx0418-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Orf virus VEGF-E Recombinant Protein |
|
300-044 |
ReliaTech |
5 µg |
EUR 136.5 |
|
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|
300-044S |
ReliaTech |
2 µg |
EUR 73.5 |
|
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|
300-045 |
ReliaTech |
20 µg |
EUR 357 |
|
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|
300-046 |
ReliaTech |
20 µg |
EUR 194.25 |
|
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|
300-046S |
ReliaTech |
5 µg |
EUR 94.5 |
|
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
 Orf Virus VEGF-E |
|
MBS691797-002mg |
MyBiosource |
0.02mg |
EUR 695 |
Orf Virus VEGF-E |
|
MBS691797-5x002mg |
MyBiosource |
5x0.02mg |
EUR 2830 |
Orf Virus VEGF-E |
|
MBS691891-0005mg |
MyBiosource |
0.005mg |
EUR 350 |
Orf Virus VEGF-E |
|
MBS691891-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1275 |
Orf Virus VEGF-E |
|
MBS691947-0002mg |
MyBiosource |
0.002mg |
EUR 265 |
Orf Virus VEGF-E |
|
MBS691947-5x0002mg |
MyBiosource |
5x0.002mg |
EUR 890 |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
|
PROTQ2F842 |
BosterBio |
Regular: 10ug |
EUR 250 |
|
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691480-002mg |
MyBiosource |
0.02mg |
EUR 440 |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691480-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1685 |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691994-0005mg |
MyBiosource |
0.005mg |
EUR 300 |
Orf Virus VEGF-E, Heparin-binding |
|
MBS691994-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1050 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
|
QP10912-1mg |
EnQuireBio |
1mg |
EUR 6181.2 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
|
QP10912-2ug |
EnQuireBio |
2ug |
EUR 186 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
|
QP10912-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Anti-Orf Virus VEGF-E Antibody |
|
102-PA70 |
ReliaTech |
50 µg |
EUR 115.5 |
|
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
 Human PDGFC / VEGFE, Fc Tag |
|
E24PHA208 |
EnoGene |
50 μg |
EUR 180 |
 Human PDGFC / VEGFE, His Tag |
|
E24PHA209 |
EnoGene |
50 μg |
EUR 225 |
VEGF E (Orf Virus) |
|
cyt-263 |
ProSpec Tany |
2µg |
EUR 60 |
|
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
 Cynomolgus / Rhesus Macaque PDGFC / VEGFE, Fc Tag |
|
E24PCA081 |
EnoGene |
50 μg |
EUR 180 |
 Cynomolgus / Rhesus Macaque PDGFC / VEGFE, His Tag |
|
E24PCA082 |
EnoGene |
50 μg |
EUR 225 |
 Recombinant Orf virus 10 kDa fusion protein |
|
MBS1129089-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1015 |
Recombinant Orf virus 10 kDa fusion protein |
|
MBS1129089-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 580 |
Recombinant Orf virus 10 kDa fusion protein |
|
MBS1129089-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 765 |
Recombinant Orf virus 10 kDa fusion protein |
|
MBS1129089-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 695 |
Recombinant Orf virus 10 kDa fusion protein |
|
MBS1129089-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 895 |
) Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS1202811-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS1072246-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS7038987-002mg |
MyBiosource |
0.02mg |
EUR 1335 |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS7038987-01mg |
MyBiosource |
0.1mg |
EUR 2300 |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS7038987-5x01mg |
MyBiosource |
5x0.1mg |
EUR 10300 |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS7038988-002mg |
MyBiosource |
0.02mg |
EUR 1330 |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS7038988-01mg |
MyBiosource |
0.1mg |
EUR 2295 |
Recombinant Orf virus Protein F9 homolog (A3R) |
|
MBS7038988-5x01mg |
MyBiosource |
5x0.1mg |
EUR 10295 |
) Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics anti-PDGF-C) |
|
E24CHA317 |
EnoGene |
100 μg |
EUR 225 |
|
Description: Available in various conjugation types. |
Hepatitis E virus ORF 3 Recombinant Protein |
|
53-335 |
ProSci |
0.01 mg |
EUR 651.3 |
|
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|
53-336 |
ProSci |
0.01 mg |
EUR 651.3 |
|
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|
53-337 |
ProSci |
0.01 mg |
EUR 651.3 |
|
Description: Hepatitis E virus ORF 2 Recombinant Protein |
, partial) Recombinant Orf virus Protein F9 homolog (A3R), partial |
|
MBS7061474-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Orf virus Protein F9 homolog (A3R), partial |
|
MBS7061495-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
abx263083-10mg |
Abbexa |
10 mg |
EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
20-abx263083 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
abx263083-25mg |
Abbexa |
25 mg |
EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|
abx263083-5mg |
Abbexa |
5 mg |
EUR 225 |
) Recombinant Figwort mosaic virus Movement protein (ORF I) |
|
MBS1050972-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1200 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
|
MBS1050972-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 850 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
|
MBS1050972-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 990 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
|
MBS1050972-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1020 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
|
MBS1050972-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1125 |
) Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1235484-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1235484-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1235484-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1235484-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1235484-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1131598-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1131598-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1131598-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1131598-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1131598-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1250494-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1250494-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1250494-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1250494-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1250494-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1007636-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1007636-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1007636-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1007636-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1007636-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1092759-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1092759-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1092759-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1092759-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
|
MBS1092759-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
) Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
|
MBS1432961-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1045 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
|
MBS1432961-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 620 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
|
MBS1432961-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 795 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
|
MBS1432961-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 720 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
|
MBS1432961-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 930 |
 Protein) Virus Measles Virus (MeV) Protein |
|
abx670263-1ml |
Abbexa |
1 ml |
EUR 543.6 |
|
|
) Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1184457-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1205 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1184457-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 855 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1184457-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 995 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1184457-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1030 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1184457-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1033786-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1205 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1033786-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 855 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1033786-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 995 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1033786-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1030 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1033786-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1093694-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1205 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1093694-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 855 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1093694-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 995 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1093694-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1030 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
|
MBS1093694-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
 Recombinant Walleye dermal sarcoma virus ORF-B protein |
|
MBS7041397-002mg |
MyBiosource |
0.02mg |
EUR 1615 |
Recombinant Walleye dermal sarcoma virus ORF-B protein |
|
MBS7041397-01mg |
MyBiosource |
0.1mg |
EUR 2570 |
Recombinant Walleye dermal sarcoma virus ORF-B protein |
|
MBS7041397-5x01mg |
MyBiosource |
5x0.1mg |
EUR 11530 |
 Protein) Virus West Nile Virus (WNV) Protein |
|
abx670276-100ug |
Abbexa |
100 ug |
EUR 794.4 |
|
|
) Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
|
MBS1130671-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
|
MBS1130671-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
|
MBS1130671-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
|
MBS1130671-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
|
MBS1130671-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
) Recombinant Carnation etched ring virus Movement protein (ORF I) |
|
MBS1056689-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1195 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
|
MBS1056689-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 845 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
|
MBS1056689-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 985 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
|
MBS1056689-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1015 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
|
MBS1056689-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1125 |
 Protein) Virus Hepatitis A Virus (HAV) Protein |
|
abx670259-1ml |
Abbexa |
1 ml |
EUR 427.2 |
|
|
 Protein) Virus Yellow Fever Virus (YFV) Protein |
|
abx670277-100ug |
Abbexa |
100 ug |
EUR 644.4 |
|
|
) Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
|
MBS1213579-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1040 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
|
MBS1213579-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 615 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
|
MBS1213579-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 790 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
|
MBS1213579-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 715 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
|
MBS1213579-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 925 |
) Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
|
MBS1057844-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1085 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
|
MBS1057844-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 675 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
|
MBS1057844-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 840 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
|
MBS1057844-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 785 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
|
MBS1057844-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 980 |
 Protein) Virus Varicella Zoster Virus (VZV) Protein |
|
abx670269-1ml |
Abbexa |
1 ml |
EUR 794.4 |
|
|
Hepatitis E Virus ORF3 Protein |
|
20-abx260138 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Hepatitis E Virus ORF3 Protein |
|
abx260138-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF3 Protein |
|
abx260138-5g |
Abbexa |
5 µg |
EUR 350 |
 Recombinant Walleye dermal sarcoma virus ORF-B protein, partial |
|
MBS7091428-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1149572-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1149572-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1149572-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1149572-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1149572-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1261084-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1261084-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1261084-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1261084-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1261084-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1053151-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1053151-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1053151-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1053151-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1053151-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1013968-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1013968-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1013968-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1013968-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
|
MBS1013968-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
 Protein) Virus Respiratory Syncytial Virus (RSV) Protein |
|
abx670078-01mg |
Abbexa |
0.1 mg |
EUR 594 |
|
|
) Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1125301-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1125301-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1125301-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1125301-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1125301-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1236167-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1236167-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1236167-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1236167-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1236167-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1208165-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1020 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1208165-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 595 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1208165-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 775 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1208165-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 690 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1208165-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 910 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1161869-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1161869-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1161869-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1161869-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1161869-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1255499-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1255499-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1255499-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1255499-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1255499-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1029118-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1029118-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1029118-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1029118-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
|
MBS1029118-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
 Varicella Zoster Virus ORF26 Protein |
|
20-abx260176 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Varicella Zoster Virus ORF26 Protein |
|
abx260176-20g |
Abbexa |
20 µg |
EUR 950 |
Tags:
genome annotation,
genome bins,
genome biology,
genome browser,
genome browser ucsc,
genome definition,
genome editing,
genome genpact login,
genome in a sentence,
genome link,
genome medical,
genome of saccharomyces cerevisiae,
genome project,
genome research,
genome sequence,
genome sequencing,
genome sequencing machine,
genome testing,
genome-wide association studies,
genomeme,
genomes meaning
